Concepedia

Author

Sofia Vakalopoulou

Aristotle University of Thessaloniki

Also Known As

Aristidis Slavakis, S Vakalopoulou, S. VAKALOPOULOU, S. Vakalopoulou, SOFIA Vakalopoulou, Sofia Vakalopoulou

101

Publications

839

Citations

16

H-Index

43

Concepts

All Affiliations

Aristotle University of ThessalonikiHippocration General HospitalIppokrateio General Hospital of ThessalonikiNational and Kapodistrian University of AthensDemocritus University of Thrace
SV

About

Sofia Vakalopoulou is an author at Aristotle University of Thessaloniki specializing in medicine, hematology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

207

2

Emergency Medicine

2

2

32

3

Health Sciences

1

1

39

4

Public Health

1

1

61

5

Cell Biology

1

1

49

Sofia Vakalopoulou

×

17

Publications

431

Citations

12

H-Index

YearCitations

Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.

Vasilia Garypidou, Sofia Vakalopoulou, Dimokritos Dimitriadis,

PubMed

2004

61

Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes

Irene Bouchliou, Paraskevi Miltiades, Evangelia Nakou,

Clinical Immunology

2011

49

Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

Themistoklis Vassiliadis, Vassilia Garipidou, Vassilios Perifanis,

American Journal of Hematology

2005

45

Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia

Vassilios Perifanis, Timoleon‐Achilleas Vyzantiadis, Sofia Vakalopoulou,

Annals of Hematology

2006

39

Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival

Themistoklis Vassiliadis, Alexander Mpoumponaris, Sofia Vakalopoulou,

Hepatology Research

2010

37

The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture

Timoleon‐Achilleas Vyzantiadis, Maria Charizopoulou, Fotini Adamidou,

Thrombosis and Haemostasis

2013

28

The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B

Panagiotis Anagnostis, Sofia Vakalopoulou, Timoleon‐Achilleas Vyzantiadis,

Haemophilia

2013

27

The role of sclerostin/dickkopf‐1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross‐sectional study

Panagiotis Anagnostis, Sofia Vakalopoulou, D. Christoulas,

Haemophilia

2017

23

Rivaroxaban Use in Patients with Hemoglobinopathies

Chrysoula Apostolou, Philippos Klonizakis, Maria Mainou,

Hemoglobin

2017

21

The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine

Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros P. Vassilakopoulos,

Clinical Cancer Research

2015

18

Page 1